All News #Library
Biotech
NeuroSigma Launches Monarch for Pediatric ADHD After Pilot Study
18 Nov 2025 //
GLOBENEWSWIRE
Neurosigma Reveals Real-Time Brain Activity Effects Of eTNS
03 Nov 2025 //
GLOBENEWSWIRE
NeuroSigma Gets Patent Allowance for Monarch eTNS System in China
10 Jun 2025 //
GLOBENEWSWIRE
NeuroSigma Patent Protects Trigeminal Nerve Use For Dyslexia
22 Jan 2025 //
GLOBENEWSWIRE
Monarch eTNS ADHD Trial At King’s College Completes Enrollment
13 Jan 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support